ArticleAdvances in pharmacology (San Diego, Calif.)2022

ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.

HaiFeng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.